Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use

27 Nov 2019

Abstract excerpt

BACKGROUND: Patients diagnosed as diffuse large B cell lymphoma (DLBCL) with CD5 positive normally have a worse outcome and poorly respond to the regulatory treatment strategy. RESULTS: We recently reported differently expressed tRFs and their potential target-genes of tRFs in patients with CD5+ R/R DLBCL. Differently expressed tRFs were detected by Illumina NextSeq instrument and the results were verified by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Lymphoma Diagnosis and Treatment
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31775867
DOI: 10.1186/s13062-019-0255-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical usePMID 31775867Read ↗

Multiple Omics Analysis Reveals E2F5 Predict Prognostic Biomarker in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Large-scale transcriptome data analysis reveals prognostic signature genes for overall survival prediction in diffuse large B cell lymphomaSemantic proximity Read ↗

Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell LymphomaSemantic proximity Read ↗

Establishment of a typing model for diffuse large B-cell lymphoma based on B-cell receptor repertoire sequencing.Semantic proximity Read ↗

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapySemantic proximity Read ↗

Tumor Purity-Related Genes for Predicting the Prognosis and Drug Sensitivity of DLBCL PatientsSemantic proximity Read ↗

Expression profiles of long non-coding RNAs ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2 in diffuse large B-cell lymphoma: a case-control study focusing on GCB and non-GCB subtypesSemantic proximity Read ↗

Systematic Analysis Of Expression Profiles Of SRSF Family Members For Prognostic Application In DLBCLSemantic proximity Read ↗

A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphomaSemantic proximity Read ↗

OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma.Semantic proximity Read ↗

The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.